OrbiMed Advisors Israel II Ltd — SEC insider filings
SEC reporting owner CIK 1682093. 21 insider filings on record with FilingPulse; latest filed 2026-09-30.
Transaction summary — filings shown
Covers all 21 filings on record, filed 2020-09-17 to 2026-09-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 19 legs across 7 filings — 12,989,815 shares, $64,392,637 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 46 legs across 10 filings — 1,954,859 shares, $11,265,792 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 45.
- Largest priced transaction: purchase of 660,000 shares @ $17.00 ($11,220,000) in Upstream Bio, Inc., filed 2024-10-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ADARx Pharmaceuticals, Inc. (ADRX) | Director, 10% owner | 2 | 3 legs · 950,000 sh · $16,150,000 | — | 16 |
| Adicet Bio, Inc. (ACET) | 10% owner | 7 | 9 legs · 9,000,000 sh · $14,328,750 | 4 legs · 104,658 sh · $674,847 | 8 |
| Upstream Bio, Inc. (UPB) | Director, 10% owner | 1 | 2 legs · 825,000 sh · $14,025,000 | — | 6 |
| Galecto, Inc. (GLTO) | 10% owner | 8 | 2 legs · 733,333 sh · $10,999,995 | 36 legs · 1,504,628 sh · $2,298,561 | 15 |
| LogicBio Therapeutics, Inc. (LOGC) | Director, 10% owner | 1 | 3 legs · 1,481,482 sh · $8,888,892 | — | — |
| 89bio, Inc. (ETNB) | 10% owner | 2 | — | 6 legs · 345,573 sh · $8,292,384 | — |
Insider filings — OrbiMed Advisors Israel II Ltd
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-30 | 4 | ADARx Pharmaceuticals, Inc. (ADRX) jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VII LLC, OrbiMed Israel GP II, L.P., OrbiMed Genesis GP LLC | Conversion (C): 10,690,530 · Conversion (C): 2,000,962 · Conversion (C): 769,601 · Conversion (C): 564,187 · Purchase (P): 300,249 @ $17 · Conversion (C): 7,127,019 · +13 more | EDGAR |
| 2026-09-24 | 3 | ADARx Pharmaceuticals, Inc. (ADRX) jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VII LLC, OrbiMed Israel GP II, L.P. | Holdings only — no transactions reported | EDGAR |
| 2026-04-09 | 4 | Adicet Bio, Inc. (ACET) jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP V LLC, OrbiMed Capital GP VI LLC, OrbiMed Genesis GP LLC, OrbiMed Israel GP II, L.P., OrbiMed Israel GP Ltd., OrbiMed Israel BioFund GP Limited Partnership | Sale (S): 29,319 @ $6.53 · Sale (S): 2,400 @ $6.38 · Sale (S): 32,523 @ $6.29 · Sale (S): 40,416 @ $6.52 | EDGAR |
| 2025-10-10 | 4 | Adicet Bio, Inc. (ACET) jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP V LLC, OrbiMed Capital GP VI LLC, OrbiMed Genesis GP LLC, OrbiMed Israel GP II, L.P., OrbiMed Israel GP Ltd., OrbiMed Israel BioFund GP Limited Partnership | Purchase (P): 1,500,000 @ $1 · Purchase (P): 3,500,000 @ $1 | EDGAR |
| 2024-10-17 | 4 | Upstream Bio, Inc. (UPB) jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VIII LLC, OrbiMed Israel GP II, L.P. | Conversion (C): 721,956 · Purchase (P): 165,000 @ $17 · Conversion (C): 2,887,833 · Purchase (P): 660,000 @ $17 · Conversion (C): 524,500 (derivative) · Conversion (C): 2,098,000 (derivative) · +2 more | EDGAR |
| 2024-01-26 | 4 | Adicet Bio, Inc. (ACET) jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP V LLC, OrbiMed Capital GP VI LLC, OrbiMed Genesis GP LLC, OrbiMed Israel GP II, L.P., OrbiMed Israel GP Ltd., OrbiMed Israel BioFund GP Limited Partnership | Purchase (P): 1,841,100 @ $2.40 · Purchase (P): 242,200 @ $2.40 · Purchase (P): 1,041,700 @ $2.40 | EDGAR |
| 2023-08-17 | 4 | Galecto, Inc. (GLTO) jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC, OrbiMed Israel GP II, L.P., OrbiMed Capital GP VII LLC | Sale (S): 38,327 @ $0.75 · Sale (S): 248,819 @ $0.75 · Sale (S): 535,534 @ $0.75 | EDGAR |
| 2023-08-02 | 4 | Galecto, Inc. (GLTO) jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC, OrbiMed Israel GP II, L.P., OrbiMed Capital GP VII LLC | Sale (S): 26,622 @ $3 · Sale (S): 29,700 @ $3 · Sale (S): 153,078 @ $3 | EDGAR |
| 2023-07-27 | 4 | Galecto, Inc. (GLTO) jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC, OrbiMed Israel GP II, L.P., OrbiMed Capital GP VII LLC | Sale (S): 7,800 @ $2.92 · Sale (S): 4,700 @ $2.92 · Sale (S): 26,700 @ $2.92 | EDGAR |
| 2023-07-17 | 4 | Galecto, Inc. (GLTO) jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC, OrbiMed Israel GP II, L.P., OrbiMed Capital GP VII LLC | Sale (S): 9,800 @ $2.40 · Sale (S): 52,800 @ $2.40 · Sale (S): 132,100 @ $2.40 | EDGAR |
| 2023-06-29 | 4 | Adicet Bio, Inc. (ACET) jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP V LLC, OrbiMed Capital GP VI LLC, OrbiMed Genesis GP LLC, OrbiMed Israel GP II, L.P., OrbiMed Israel GP Ltd., OrbiMed Israel BioFund GP Limited Partnership, Chimovits Erez | Purchase (P): 125,000 @ $2.09 · Purchase (P): 250,000 @ $2.09 · Purchase (P): 442,000 @ $2.09 · Purchase (P): 58,000 @ $2.09 | EDGAR |
| 2023-04-17 | 4 | Galecto, Inc. (GLTO) jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC, OrbiMed Israel GP II, L.P., OrbiMed Capital GP VII LLC | Sale (S): 703 @ $1.82 · Sale (S): 3,784 @ $1.82 · Sale (S): 9,459 @ $1.82 · Sale (S): 2,091 @ $1.86 · Sale (S): 11,245 @ $1.86 · Sale (S): 28,110 @ $1.86 · +3 more | EDGAR |
| 2023-04-12 | 4 | Galecto, Inc. (GLTO) jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC, OrbiMed Israel GP II, L.P., OrbiMed Capital GP VII LLC | Sale (S): 2,584 @ $1.79 · Sale (S): 13,899 @ $1.79 · Sale (S): 34,745 @ $1.79 · Sale (S): 703 @ $1.82 · Sale (S): 3,784 @ $1.82 · Sale (S): 9,459 @ $1.82 · +3 more | EDGAR |
| 2023-04-07 | 4 | Galecto, Inc. (GLTO) jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC, OrbiMed Israel GP II, L.P., OrbiMed Capital GP VII LLC | Sale (S): 4,687 @ $2.18 · Sale (S): 25,220 @ $2.18 · Sale (S): 63,058 @ $2.18 · Sale (S): 487 @ $2 · Sale (S): 2,620 @ $2 · Sale (S): 6,558 @ $2 | EDGAR |
| 2022-01-27 | 4 | 89bio, Inc. (ETNB) jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VI LLC, OrbiMed Israel GP II, L.P. | Sale (S): 24,546 @ $8.40 · Sale (S): 24,545 @ $8.40 · Sale (S): 10,742 @ $8.38 · Sale (S): 10,740 @ $8.38 | EDGAR |
| 2021-12-14 | 4 | Adicet Bio, Inc. (ACET) jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP V LLC, OrbiMed Capital GP VI LLC, OrbiMed Genesis GP LLC, OrbiMed Israel GP II, L.P., OrbiMed Israel GP Ltd., OrbiMed Israel BioFund GP Limited Partnership | Grant/award (A): 214,285 @ $14 | EDGAR |
| 2021-02-18 | 4 | Adicet Bio, Inc. (ACET) jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP V LLC, OrbiMed Capital GP VI LLC, OrbiMed Israel GP II, L.P., OrbiMed Israel GP Ltd., OrbiMed Israel BioFund GP Limited Partnership | Grant/award (A): 420,299 @ $13 · Grant/award (A): 104,050 @ $13 | EDGAR |
| 2020-11-04 | 4 | Galecto, Inc. (GLTO) jointly with ORBIMED ADVISORS LLC, OrbiMed Israel GP II, L.P., OrbiMed Capital GP VII LLC, OrbiMed Genesis GP LLC | Conversion (C): 2,055,824 · Conversion (C): 822,311 · Conversion (C): 191,787 · Purchase (P): 523,833 @ $15 · Purchase (P): 209,500 @ $15 · Grant/award (A): 148,395 (derivative) @ $27.11 · +11 more | EDGAR |
| 2020-10-05 | 4 | LogicBio Therapeutics, Inc. (LOGC) jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VI LLC, OrbiMed Israel GP II, L.P., OrbiMed Genesis GP LLC | Purchase (P): 545,974 @ $6 · Purchase (P): 639,212 @ $6 · Purchase (P): 296,296 @ $6 | EDGAR |
| 2020-09-23 | 4 | 89bio, Inc. (ETNB) jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VI LLC, OrbiMed Israel GP II, L.P. | Sale (S): 137,500 @ $28 · Sale (S): 137,500 @ $28 | EDGAR |
| 2020-09-17 | 4 | Adicet Bio, Inc. (ACET) jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP V LLC, OrbiMed Capital GP VI LLC, OrbiMed Israel GP II, L.P., OrbiMed Israel GP Ltd., OrbiMed Israel BioFund GP Limited Partnership | Grant/award (A): 4,822,960 · Grant/award (A): 902,885 · Grant/award (A): 292,607 · Grant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-16 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1682093 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs